--2021/Q35.781M / ----
OKAY
833230
CHANGFU CO.,LTD
871396
Gansu Longshenrongfa Pharmaceutical Industry
300534
4
Tibet Duo Rui Pharmaceutical
301075
5
Chengda Pharmaceuticals
301201
US Stock MarketDetailed Quotes
KYN Kayne Anderson MLP/Midstream Investment Co
- 12.970
- +0.140+1.09%
Close Apr 1 16:00 ET
- 12.970
- 0.0000.00%
Post 16:05 ET
2.19BMarket Cap2.36P/E (TTM)
13.020High12.795Low321.11KVolume12.810Open12.830Pre Close4.15MTurnover0.19%Turnover Ratio2.36P/E (Static)169.13MShares13.47752wk High0.86P/B2.19BFloat Cap8.62552wk Low1.06Dividend TTM169.13MShs Float14.818Historical High8.17%Div YieldTTM1.75%Amplitude0.557Historical Low12.921Avg Price1Lot Size
Kayne Anderson MLP/Midstream Investment Co Key Stats
Kayne Anderson MLP/Midstream Investment Co Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 0 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Market Insights
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings